Longleaf Partners, managed by Southeastern Asset Management, released its first-quarter 2026 investor letter for its ...

After opening down around 1.5%, the S&P/ASX 200 staged a respectable recovery by lunchtime on Tuesday in Sydney, trimming losses to about 0.4%. Not exactly a heroic comeback, but enough to suggest ...

A video posted on X by Nick Shirley — a far-right influencer who received money from Polymarket’s chief marketing officer, Matthew Modabber, before the post was made — is se ...

Elon Musk is not a Bruce Springsteen fan. Musk criticized Springsteen twice on Monday, May 25, on X, seemingly in response to Springsteen's take on the Musk-led DOGE cuts of the United States Agency ...

NEW YORK, NEW YORK - APRIL 11: The Wall Street street sign is seen outside of the New York Stock Exchange during morning trading on April 11, 2025 in New York City. Stocks continued to slide amid ...

Morgans has updated its ratings on 3 shares. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get ...

S&P/ASX 200 Index (ASX: XJO) shares are up 0.8% to 8,865.9 points on Thursday. The market has rallied on hopes of a US-Iran peace deal. Meanwhile, Morgans has updated its ratings and price targets on ...

Reply to: Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection In total, 57 patients received ≥1 dose of Temab-A in dose escalation; 3.0 mg/kg once every 3 ...

aDepartment of Gastrointestinal Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada bDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer ...

Urobo Biotech, a student-led South African startup using biotechnology to tackle plastic pollution, has been named one of the top 60 teams in the Hult Prize, a prestigious international competition ...

Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial While the ...